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A B S T R A C T
Genome-wide association studies (GWAS) suggest that Alzheimer’s disease (AD) is partly explained by a burden
of risk alleles (single nucleotide polymorphisms; SNPs) with relatively small effects. However, the mechanisms
by which these loci cumulatively confer susceptibility remain largely unknown. Accumulating evidence suggests
an association between increased AD risk allele burden (measured via a polygenic risk profile score; AD-RPS)
with reduced hippocampal volume (HV) across a number of independent cohorts. These lines of research suggest
that the reduced HV may be a causal mechanism of risk in the development of late-onset Alzheimer’s disease
(AD). However, as RPS assesses broad, cumulative genetic risk, little is known about the biological processes
which may explain this observation. Here, we leverage GWAS data from i) 17,008 late onset AD cases & 37,154
controls and ii) hippocampal volume (N=12,147; N=9707) to explore putative pathways that may explain
this association. We first demonstrate an association between whole genome AD-RPS and HV (PT < 0.5,
Z=−2.07, P=0.038), confirming previous associations. Second, we restrict our analysis to SNPs within AD
genes within a microglia mediated immunity network (NGENES= 56). A microglia AD-RPS was further associated
with HV (PT < 0.01; Z=−2.152, P=0.031). Last, using a competitive, permutation based approach, we show
that the common variation within this candidate gene-set is associated with HV, controlling for SNP set-size
(P= 0.024). Together, the observations suggest that the relationship between AD and HV is partially explained
by genes within an AD-linked microglia mediated immunity network.
1. Introduction
Genome-wide association studies (GWAS) demonstrate that risk for
Alzheimer’s disease (AD) is partly explained by a large number of single
nucleotide variants with relatively small effects (Lambert et al., 2013;
Sims et al., 2017). The cumulative burden of these risk allele can be
estimated via risk profile score (RPS) analysis. Emerging evidence
suggests that the combined effect of the AD-RPS may influence AD via
risk mechanisms such as reduced cognitive ability (Del-Aguila et al.,
2018; Ge et al., 2018; Louwersheimer et al., 2016; Mormino et al.,
2016), increases in AD – related histopathology (Louwersheimer et al.,
2016; Mormino et al., 2016) and other physical health markers
(Hagenaars et al., 2018). However, the biological mechanisms by which
genetic risk for AD confer susceptibility remains relatively unknown.
Genetic neuroimaging studies have recently shown that the cumulative
impact of AD risk alleles are associated with markers of brain health
such as cortical (Li et al., 2018; Sabuncu et al., 2012) and hippocampal
morphometry (Axelrud et al., 2018; Biffi et al., 2010; Foley et al., 2017;
Lupton et al., 2016; Mormino et al., 2016). These observations suggest
that the genetic architecture of AD may overlap with genetic variation
that influences individual variability in hippocampal volume, a hy-
pothesis that is supported by a recent GWAS of hippocampal volume
(Hibar et al., 2017). Risk alleles for AD may confer risk of a smaller
hippocampus throughout the lifespan (which provides reduced resi-
lience in later life), supported by observations between AD – RPS and
hippocampal volume in early adulthood (Foley et al., 2017; Mormino
et al., 2016). These AD risk alleles may also associate with an accelerate
trajectory of hippocampal atrophy (Harrison et al., 2016).
These studies use an AD-RPS that is estimated using a large number
of alleles across the entire genome. Therefore, the biological pathways
that underpin these putative associations remain elusive. A recent AD-
GWAS suggests that common and rare genetic variation that confers
risk may cluster within a network of molecules that coordinate micro-
glia – mediated innate immunity (Sims et al., 2017). Preliminary
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evidence suggest that AD-RPS estimated via AD risk alleles within genes
that play a role in immunity may contribute to peripheral markers of
AD (Morgan et al., 2017). However, little work has explored the re-
lationship between AD –linked genes with immune function and in vivo
makers of brain health linked to AD, such as hippocampal volume (HV).
In the current study, we aim to test the hypothesis that AD-linked
single nucleotide variants within the recently identified gene-network
that orchestrates microglia – mediated innate immunity may partly
explain the emerging relationship between AD and hippocampal vo-
lume. We perform this analysis using GWAS summary statistics from i)
the latest AD GWAS (Lambert et al., 2013) and ii) recent GWAS of
hippocampal volume (Elliott et al., 2018; Hibar et al., 2015). Our first
objective is to replicate the association between whole genome AD-RPS
and HV. Our second objective is to assess whether the microglia gene-
network linked to AD contributes to this putative association.
2. Methods & materials
2.1. Samples
Polygenic score calculations were performed according to the pro-
cedure first described by the International Schizophrenia Consortium
(International Schizophrenia et al., 2009). Training data were from the
International Genomics of Alzheimer’s Project consortium that com-
prises 17,008 AD cases and 37,154 control subjects (Lambert et al.,
2013). These data are publicly available from http://www.pasteur-lille.
fr/en/recherche/u744/igap/igap_download.php. Hippocampal volume
GWAS data were downloaded from the Enhancing Neuroimaging Ge-
netics through Meta-Analysis (ENIGMA) GWAS analysis of subcortical
volumes, available at http://enigma.ini.usc.edu/research/download-
enigma-gwas-results/ and comprised of 13,163 individuals (Hibar
et al., 2015). A replication data set was also acquired by averaging
summary statistics derived from left and right hippocampal volume
GWAS in UK Biobank (Image Derived Phenotype IDs: 2667 & 2682),
available at http://big.stats.ox.ac.uk/download_page, comprising of
9707 individuals (Elliott et al., 2018). All GWAS data was corrected for
demographic and genetic confounds.
2.2. Microglia-mediated innate immunity network selection
To explore the putative impact of AD risk alleles linked to microglia
–mediated innate immunity, we restrict our AD-RPS and set-based
analysis to loci within genes previously established via protein – protein
interaction analysis (Sims et al., 2017). Briefly, this 56 gene network
was created by protein-protein interaction analysis of gene modules
enriched for variants associated with AD that were previously derived
from brain co-expression networks (International Genomics of
Alzheimer's Disease, 2015). We note that although this SNP set included
genetic variants spanning all genes within the network, it did not in-
clude the rare variants identified via exome sequencing as AD effect
sizes were only available for common risk alleles (minor allele fre-
quency (MAF) > 0.01) and did not include the top hits in PLCG2 and
ABI3.
2.3. Genotype quality control and Alzheimer’s disease risk profile score
(RPS) creation
For the AD-RPS, SNPs in the 1000 Genomes Project (phase 3) were used
as reference data. Variants within both the major histocompatibility com-
plex MHC (chr 6: 26,000–34,000 kb) and APOE (chr 19: 44,400–46,500 kb)
regions were removed from the genotype data, as previously indicated
(Tansey et al., 2018). In all cases, AD polygenic risk scores (RPS) were
created using PRSice v1.25 risk profile software (Euesden et al., 2015) using
a stringent clumping procedure [clump.p1=0.5, clump.p2=0.5,
clump.kb=300 kb, clump.r2=0.05] to remove correlated AD risk alleles.
HV summary statistics were processed/quality controlled as previously
outlined (Elliott et al., 2018; Hibar et al., 2015). A meta-analysis of beta
coefficients (for both samples; ENIGMA & UKBB) was performed using the
‘metafor’ in R (Viechtbauer, 2010).
2.4. Competitive set analysis
In order to ascertain whether microglia SNP set size was con-
tributing to putative explained variance, the relationship between AD
linked microglia –mediated immune gene network and hippocampal
volume was validated using two approaches. First, permutation analysis
was conducted to set an empirical threshold by creating AD-RPS from
1000 permuted SNP sets (Cabrera et al., 2012) controlling for both SNP
set size and IGAP significance. Second, gene set analyses in MAGMA
v1.06 (de Leeuw et al., 2015) was used to test microglia gene-set en-
richment. Briefly, common SNP association P-values were combined
into gene-wide P-values (via the MAGMA SNP-wise mean model), using
a window of 35 kb upstream and 10 kb downstream of each gene in
order to include SNPs within regulatory regions (Network and Pathway
Analysis Subgroup of Psychiatric Genomics, 2015). Only protein-coding
genes were included in the analysis (N=17,970). The gene set analysis
method was used to perform a linear regression of gene-wide associa-
tion against a gene-level for the meta-analysed (ENIGMA & UKBB HV)
data. This analysis was two-tailed and corrected for gene size and SNP
density.
3. Results
3.1. Whole genome AD-RPS, microglia AD-RPS and hippocampal volume
Consistent with prior reports, we first observed a relationship be-
tween total AD-RPS and hippocampal volume (Fig. 1; all AD-RPS, in
red). This association was significant across multiple P thresholds
(PT < 0.1–PT < 0.5; p-values above coloured bars). Including the
APOE region slightly improved the model fit (PT > 0.05, P=0.035;
PT > 0.5, P=0.007). We further observed a trend for association in
our replication cohort (UKBB: PT < 0.2–0.5, P= 0.057–0.099). We
then proceeded to restrict the AD-RPS to SNPs within the 56 genes
within the identified microglia network and re-run the analysis. The
microglia AD-RPS consisted of substantially less SNPs (Table 1), al-
though explained a similar amount of variance in HV (across a range of
P thresholds; PT < 0.001–PT < 0.01) (Fig. 1; variance explained
coded in blue). We also observed this trend in our replication sample
(PT < 0.01, P= 0.027). The putative enrichment of the microglia AD-
RPS is empirically tested in 3.2: Competitive microglia set-based
testing. SNPs that were associated the microglia AD-RPS in both sam-
ples (PT < 0.01) were present in 32/33 of the 56 AD-linked microglia-
mediated immunity genes, many of which contained more than one
independent variation (R2 < 0.05) that contributed to the AD-RPS (see
3.3 gene annotation). An analysis for AD-RPS (minus microglia SNPs)
did not significantly affect any of these observations.
3.2. Competetive microglia set-based testing
To ascertain whether the microglia AD-RPS was predictive of hip-
pocampal volume above and beyond the set size, we drew a distribution
of R2 from 1000 AD-RPS of randomly drawn IGAP SNPs. The microglia
AD-RPS explained more variance (R2) in hippocampal volume com-
pared to similar sized (number of SNPs) AD-RPS, randomly drawn SNPs
from IGAP summary statistics (see Fig. 2). Gene set analysis was also
conducted to ensure that the gene –set was associated with HV, con-
trolling for number of SNPs in the model. For gene-wide competitive
testing, 52 of the 56 genes were included in the final analysis, where 4
genes were excluded (C3AR1, INPP5D, PTPN6, IKZF1) for missing /
incomplete SNP data. The AD-linked microglia gene set was sig-
nificantly enriched for genes associated with hippocampal volume
(N=21,750, meta-analysed across ENIGMA & UKBB) compared to
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Fig. 1. All AD-RPS (SNPs across whole genome) regressed on hippocampal volume (across whole genome; red) and microglia AD-RPS (SNPs within 56 microglia-
mediated immunity genes (Sims et al., 2017; blue)). Left Y-axis= R2; Right Y axis= beta coefficients (+/− 95% confidence), X-axis= P-Threshold of AD-RPS. All
AD-RPS are performed after the removal of the APOE and MHC loci. P values are annotated above each bar that denotes variance explained (R2) at each AD-RPS/P –
threshold.
Table 1
Meta-analysis for association between AD-RPS and hippocampal volume (HV) across a progressive series of P-thresholds (PT > 0.001–0.5). All AD SNPs represents
an AD-RPS derived from common SNPs (MAF > 0.01) across the whole genome (excluding APOE and MHC region). Microglia loci represents all common SNPs
located in proximity to 56 genes implicated in the microglia – meditated innate immunity network. SNPs represents the number of AD associated risk variants
considered at each P-threshold. Results in bold reflect significant effects in the meta-analysis.
ENIGMA (N=13163) UKBB (N=9707) Meta-analysis (Z/P)
PT All AD SNPs Microglia SNPs All AD SNPs Microglia SNPs All AD SNPs Microglia SNPs
0.001 1479 16 1598 16 0.679 0.497 −2.344 0.019
0.005 5159 33 5723 34 −0.079 0.937 −2.495 0.013
0.01 8742 60 9755 61 −1.198 0.231 −2.152 0.031
0.1 45,698 221 52,308 234 −1.876 0.061 0.111 0.911
0.2 70,810 307 81,407 326 −2.128 0.033 0.070 0.944
0.5 117,446 473 136,598 529 −2.070 0.038 −0.249 0.804
Fig. 2. Variance explained (R2) by microglia AD-RPS
(SNPs within 56 microglia-mediated immunity genes
(denoted by blue dashed line) compared to 1000,
comparably sized random AD RPS SNP sets at P-
thresholds where microglia AD-RPS was significant. P
value of enrichment at dashed line represents number
of random AD-RPS that surpass microglia AD-RPS
divided by total number of random AD-RPS permu-
tations.
T.M. Lancaster, et al. Brain, Behavior, and Immunity xxx (xxxx) xxx–xxx
3
17,970 background genes, correcting for gene size/density and sample
size (β= 0.214 ± 0.0155, SE=0.107, P=0.023).
3.3. Gene annotation
To assess the individual impact of SNPs used to estimate the mi-
croglia AD-RPS in both cohorts, we map each SNP to the nearest gene
and plot each SNP effect size for both AD and HV (Fig. 3). The same 32
genes contributed to the association between microglia AD-RPS and HV
in our discovery (ENIGMA) and replication (UKBB) sample. AD risk
alleles with largest negative effect sizes for HV (intersected across
samples) include SNPs within PLCG2, BLNK, HMHA1, NCF4 &
ARHGAP24 (top 5).
4. Discussion
In the current study, we observed that whole genome AD-RPS was
associated with hippocampal volume in a large discovery data set. This
evidence suggests an overlapping genetic aetiology between
Alzheimer’s disease (AD) and Hippocampal volume (HV) (Hibar et al.,
2017). This observation supports previous studies demonstrating a re-
lationship between AD-RPS and HV (Biffi et al., 2010; Chauhan et al.,
2015; Foley et al., 2017; Lupton et al., 2016; Mormino et al., 2016).
Critically, we further show that a smaller gene network (NGENES= 56)
supporting microglia-mediated innate immunity (as identified in a re-
cent exome-wide study (Sims et al., 2017)) also show evidence for
shared genetic overlap with HV, with a similar effect size to that of all
AD risk alleles across the genome (excluding APOE and MHC regions).
Post-hoc analysis suggested that multiple, independent loci within AD
genes contributed to this association, several of which have previously
been associated with HV such as ABCA7 (Ramirez et al., 2016) and
CD33 (Wang et al., 2017). Furthermore, an intersection of effect sizes
across samples demonstrated that the most influential SNPs were in
genes such as PLCG2, BLNK, HMHA1, NCF4 & ARHGAP24. While it is
difficult to elucidate individual SNP effects in a polygenic model, we
note these genes may support biological plausible processes (such as
PLCG2-BLNK interactions and NF-kappa B signalling – which has a key
role in hippocampal plasticity (Albensi and Mattson, 2000; Meffert
et al., 2003). Our observation is also supported by recent histological
evidence showing that and AD-RPS (with and without APOE) is asso-
ciated with microglia density exclusively within the temporal lobe
(Felsky et al., 2018).
The comparable effect sizes for the whole genome AD-RPS and
microglia AD-RPS demonstrate that simple, additive linear model of
polygenic risk (i.e. whole genome risk profile scores) may not optimally
capture the variance in a genetically linked phenotype, as biological
specificity is not taken into account. Future studies that attempt to
biological annotate risk profile scores should exercise caution as var-
iance explained can vary as a function of discovery GWAS sample size,
P-threshold criteria and weighted effect sizes (Dudbridge, 2013). In the
current study, we attempted to control for the size of our candidate
microglia AD-RPS SNP set size using competitive set-based testing. Our
simulations suggest that the R2 of the microglia AD-RPS set was larger
than chance, based on a distribution of 1000 randomly drawn AD-RPS.
We present these observations with the following considerations.
First, we acknowledge that the impact of both genome-wide and mi-
croglia AD-RPS on hippocampal volume are small (< 0.05% variance
explained, in both cases). Second, as hippocampal volume was collected
across a broad age range, we cannot infer whether these associations
are fixed or dynamic across the lifespan. Hypothesis surrounding the
impact of AD risk alleles on brain structure (and associated effect sizes)
remain to be tested. Preliminary evidence suggests that while AD-RPS
effects on hippocampal volume are present in young individuals
(Axelrud et al., 2018; Foley et al., 2017), AD-RPS may influence the rate
of age/AD related hippocampal atrophy (Harrison et al., 2016). We
suggest that exploring putative dynamic effects of AD risk genes on
brain structure across the lifespan are critical for understanding when
these associations may occur. Taken together, we exercise caution of
interpretation of effect sizes/variance explained by AD-RPS in the
current study. Lastly, we solely explored a recently identified microglia-
linked gene-set and suggest that future bioinformatics research should
help to refine and uncover the principle biological gradients that un-
derpin AD genetic risk (Tansey et al., 2018). This will help to delineate
the various AD-linked process that may contribute to subcortical
Fig. 3. Diagnostic plots for microglia SNP sets for ENIGMA (N=13,163; left: β=−26.9, P=0.016, NSNPS= 60) and UK Biobank (N=9707; right: β=−0.05,
P=0.027, NSNPS= 61), both constrained to the P-threshold < 0.01. Each SNP is plotted by coefficient in the risk score (x axis) versus estimated effect size for HV in
the testing dataset (y axis). The solid black line shows the effect size estimate for the risk score on HV in each of the testing datasets. Grey bar represents 95%
confidence intervals.
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reductions in early and later-life processes. We also note that the AD-
RPS component of our analysis was derived using reference data con-
sisting of relatively common SNPs (MAF > 0.01) and did not include
the rare SNPs identified via exome –based follow studies (Sims et al.,
2017).
5. Conclusions
To conclude, the current study uses genome-wide summary datasets
to confirm an association between AD risk alleles and hippocampal
volume, with a smaller number of SNPs within a microglia mediated
immunity network explaining a comparable amount of variance, above
and beyond the size of the candidate SNP set. This provides the first
evidence that AD genetic risk factors linked to microglia function may
contribute to individual differences in brain health antecedent to the
development of AD. Specifically, our analysis suggests immunogenic
biological processes capable of influencing hippocampal plasticity, such
as NF kappa B signalling. This study represents the one of the first
pathway based approaches to explore shared genetic risk between AD
and MRI phenotypes linked to the early makers of neurodegeneration
and showcases the translational potential of pathway based polygenic
approaches in imaging genetics. We suggest that dissecting biological
pathways in AD and their biological correlates will further establish
individual-orientated clinical strategies for early detection and inter-
vention in AD.
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